Skip to main content

2025 Agenda

Image

Loading

Clinical Proteomics and Metabolomics in Biopharma Drug Discovery and Development

June 25, 2025
Multi-Omics Stage
  • Values: Offer detailed insights into proteome-level changes and integrate with genomic data to support proteogenomics, providing a multi-omics perspective.
  • Considerations: Require well-designed studies, high-quality samples, and accurate data analysis to ensure reproducibility and sensitivity.
  • Impact: Facilitate novel drug target identification and validation, advance personalized medicine, and improve disease understanding and clinical diagnostics.
Speaker(s)
Sonja Hess, Senior Director, Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D - AstraZeneca

Countdown To The Festival